Css LLC Intercept Pharmaceuticals, Inc. Transaction History

Css LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $56,150 - $97,950	-5,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $18,089 - $24,069	1,353 Added 37.1%	5,000 $81,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $26,511 - $45,995	1,083 Added 42.24%	3,647 $90,000
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $78,844 - $107,788	2,017 Added 368.74%	2,564 $106,000
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $27,934 - $60,436	487 Added 811.67%	547 $68,000

Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $5,509 - $7,240	60 New	60 $7,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $495,568 - $632,150	-9,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $52,380 - $65,484	900 Added 10.59%	9,400 $549,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $484,585 - $1.01 Million	8,500	8,500 $493,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.